Who we are
As Corporate Venture Capital unit, we play a strategic role in Evonik’s goal to become a best-in-class specialty chemicals company. ... MORE
New Sustainability Tech Fund
Investments with the primary objective to achieve CO2 mitigation by reducing and removing emissions ... MORE
What we are looking for
Start-ups that are developing future-oriented technologies and disruptive business models. ... MORE
How we invest
Our investments in outstanding business ideas are driven by financial and strategic objectives. ... MORE
Our portfolio
Innovative start-ups that have the potential to become future industry leaders, combined with a set of diverse technology fund investments. ... MORE
Media
The latest news about Evonik, its R&D activities and Venture Capital investments. ... MORE
Our Team
Experts in start-up ecosystems across the globe with offices in Germany, USA and China. ... MORE
Do you know our Linkedin Channel?
Follow Evonik Venture Capital to stay up to date on our latest investments, cooperations and news ... MORE
Latest Press Announcements
Venture Capital
Evonik Venture Capital invests in Laxxon
3D printed tablets with better drug delivery improve patients’ health. ... MORE
Portfolio Company
In Ovo raises EUR 34M to end male chick culling
Dutch AgTech scale-up closes 34M fund raise to accelerate its international growth and scale up plans. The funding is provided by impact investor ECBF and ABN AMRO and includes existing shareholders Evonik and VisVires New Protein. ... MORE
Portfolio Company
Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics
Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics, announced the closing of a Seed 2 funding of 3.2 million Euro. Evonik Venture Capital participated as a new investor. ... MORE
Venture Capital
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee, U.S.-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. ... MORE
Venture Capital
Alternative to animal testing: Evonik invests in Singapore start-up
Evonik has invested in start-up Revivo BioSystems to support the development of a realistic 4D model of human skin that provides an alternative to animal testing. ... MORE
Company
Evonik Venture Capital invests in two leading Chinese funds to access advanced material technologies
Evonik is extending its corporate venture capital activities in China with investments into GRC SinoGreen Fund V and Richland VC Fund III. ... MORE
Company
Evonik spends venture capital on sustainability funds Azolla Ventures and Chrysalix
Evonik Venture Capital has invested in two sustainability funds: Azolla Ventures I and the Chrysalix Venture Capital’s Carbon Neutrality Fund. ... MORE
Portfolio Company
Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices
Vivasure Medical announced the closing of the first tranche of €22 million ($23M) as part of its Series D financing round that could reach up to €52 million ($54M) in total. ... MORE
Portfolio Company
Citrine Informatics Wins Investment from Evonik Venture Capital
Evonik invested in Citrine Informatics, provider of the Citrine Platform, a leading AI and smart data management software platform for materials and chemicals development. ... MORE